CRISPR ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer is a research paper published in The Journal of Pathology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Mark Foundation For Cancer Research
Grant: 20‐028‐EDV
National Center for Advancing Translational Sciences
Grant: TR001453‐01
National Institutes of Health
Grant: P30CA045508‐33
Vetenskapsrådet
Grant: 2020‐03818
National Cancer Institute
Grant: 5P30CA045508
NCI NIH HHS
Grant: P30 CA045508
NCATS NIH HHS
Grant: UL1 TR001453
NCATS NIH HHS
Grant: TR001453-01
NIH HHS
Grant: P30CA045508-33
FWCI
0.47
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals